XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statement of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common Stock
Preferred Stock
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 25,594 $ 2,750 $ 225,584 $ 41,081,455 $ (41,020,933) $ 314,450
Balance (in Shares) at Dec. 31, 2022 255,940,389 2,750,000        
Sales of common stock $ 22 18,743 18,765
Sales of common stock (in Shares) 225,000          
Other sales of common stock $ 200 125,998 126,198
Other sales of common stock (in Shares) 2,000,000          
Fair value of warrants allocated to proceeds of common stock 73,802 73,802
Fair value of warrants allocated to proceeds of related party debt 95,393 95,393
Consultant and director fees payable with common shares and warrants 54,972 54,972
Shares and options issued to employees $ 99 (34,200) 67,229 33,128
Shares and options issued to employees (in Shares) 987,500          
Net Income (loss)         1,451,935 1,451,935
Balance at Mar. 31, 2023 $ 25,915 $ 2,750 246,356 41,462,620 (39,568,998) 2,168,643
Balance (in Shares) at Mar. 31, 2023 259,152,889 2,750,000        
Balance at Dec. 31, 2022 $ 25,594 $ 2,750 225,584 41,081,455 (41,020,933) 314,450
Balance (in Shares) at Dec. 31, 2022 255,940,389 2,750,000        
Net Income (loss)           448,480
Balance at Jun. 30, 2023 $ 26,483 $ 2,750 283,592 41,831,448 (40,572,453) 1,571,820
Balance (in Shares) at Jun. 30, 2023 264,829,556 2,750,000        
Balance at Mar. 31, 2023 $ 25,915 $ 2,750 246,356 41,462,620 (39,568,998) 2,168,643
Balance (in Shares) at Mar. 31, 2023 259,152,889 2,750,000        
Other sales of common stock $ 542 154,072   154,614
Other sales of common stock (in Shares) 5,416,667          
Fair value of warrants allocated to proceeds of common stock   120,386 120,386
Fair value of warrants allocated to proceeds of related party debt 50,025 50,025
Consultant and director fees payable with common shares and warrants $ 20 37,236 15,380 52,636
Consultant and director fees payable with common shares and warrants (in Shares) 200,000          
Shares and options issued to employees $ 6 24,607 24,613
Shares and options issued to employees (in Shares) 60,000          
Incremental fair value of repriced warrants 4,358   4,358
Net Income (loss)         (1,003,455) (1,003,455)
Balance at Jun. 30, 2023 $ 26,483 $ 2,750 283,592 41,831,448 (40,572,453) 1,571,820
Balance (in Shares) at Jun. 30, 2023 264,829,556 2,750,000        
Balance at Dec. 31, 2023 $ 27,597 $ 2,750 281,682 42,525,837 (42,033,136) 804,730
Balance (in Shares) at Dec. 31, 2023 275,964,958 2,750,000        
Sales of common stock $ 510 255,413 255,923
Sales of common stock (in Shares) 5,100,000          
Fair value of warrants allocated to proceeds of common stock 99,077 99,077
Fair value of warrants allocated to proceeds of related party debt 209,943 209,943
Fair value of beneficial conversion feature allocated to proceeds of related party debt 146,405 146,405
Consultant and director fees payable with common shares and warrants 43,437 43,437
Shares and options issued to employees (270,549) 320,246 49,697
Net Income (loss)         (1,387,718) (1,387,718)
Balance at Mar. 31, 2024 $ 28,107 $ 2,750 54,570 43,556,921 (43,420,854) 221,494
Balance (in Shares) at Mar. 31, 2024 281,064,958 2,750,000        
Balance at Dec. 31, 2023 $ 27,597 $ 2,750 281,682 42,525,837 (42,033,136) 804,730
Balance (in Shares) at Dec. 31, 2023 275,964,958 2,750,000        
Net Income (loss)           (2,928,154)
Balance at Jun. 30, 2024 $ 28,195 $ 2,750 110,874 44,394,892 (44,961,290) (424,579)
Balance (in Shares) at Jun. 30, 2024 281,947,151 2,750,000        
Balance at Mar. 31, 2024 $ 28,107 $ 2,750 54,570 43,556,921 (43,420,854) 221,494
Balance (in Shares) at Mar. 31, 2024 281,064,958 2,750,000        
Sales of common stock $ 87 38,734 38,821
Sales of common stock (in Shares) 877,193          
Fair value of warrants allocated to proceeds of common stock 11,178 11,178
Fair value of warrants allocated to proceeds of related party debt 364,422 364,422
Fair value of beneficial conversion feature allocated to proceeds of related party debt 392,905 392,905
Consultant and director fees payable with common shares and warrants 69,624 69,624
Shares and options issued to employees $ 1 (13,320) 30,732 17,413
Shares and options issued to employees (in Shares) 5,000          
Net Income (loss)         (1,540,436) (1,540,436)
Balance at Jun. 30, 2024 $ 28,195 $ 2,750 $ 110,874 $ 44,394,892 $ (44,961,290) $ (424,579)
Balance (in Shares) at Jun. 30, 2024 281,947,151 2,750,000